Skip to main content
Balaji Amines Ltd. logo

Balaji Amines Ltd. — Investor Relations & Filings

Ticker · BALAMINES ISIN · INE050E01027 LEI · 3358009DS8RG4Z8QBD69 BSE.NS Manufacturing
Open in API
Filings indexed 741 across all filing types
Latest filing 2025-09-27 Regulatory Filings
Country IN India
Listing BSE.NS BALAMINES

About Balaji Amines Ltd.

https://www.balajiamines.com/

Balaji Amines Ltd. is a leading manufacturer specializing in Aliphatic Amines, their derivatives, and specialty chemicals. The company produces a diverse range of products, including Methylamines, Ethylamines, and specialty chemicals such as N-Methyl-2-Pyrrolidone (NMP), Morpholine, Dimethylformamide (DMF), and Gamma-Butyrolactone (GBL). Its portfolio serves critical sectors including pharmaceuticals, agrochemicals, refineries, water treatment, and personal care. Utilizing advanced manufacturing technologies and vertically integrated processes, the company maintains a significant market presence in the production of amines and downstream derivatives. Balaji Amines is recognized for its large-scale production capacity and its role as a key supplier of essential chemical intermediates used in the synthesis of active pharmaceutical ingredients and crop protection chemicals.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement disclosure under SEBI Listing Regulations. It mentions the opening of a special window for re-lodgement of transfer requests of physical shares. The document is short (1410 characters) and serves as a regulatory announcement rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures.
2025-09-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations ahead of the announcement of the company's unaudited financial results for the quarter and half year ended 30th September 2025. It does not contain any financial data or results itself, nor does it announce the results but rather the trading restrictions before the results are declared. The document is short (1872 characters) and serves as a regulatory compliance notification related to insider trading restrictions. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a financial report or earnings release.
2025-09-27 English
General Updates
Regulatory Filings Classification · 100% confidence The document is a communication addressed to stock exchanges and shareholders regarding compliance with SEBI regulations on updating PAN, KYC, and nomination details for shareholders holding shares in physical form. It references SEBI circulars and mandates effective dates for compliance. The document provides instructions and forms for shareholders to update their details and warns about consequences of non-compliance, such as withholding dividend payments. There is no financial data, no report attached or announced, no earnings or management discussion, no board changes, no voting results, no legal proceedings, no capital changes, and no merger activity. The document is an official regulatory announcement informing shareholders and stock exchanges about regulatory compliance requirements and procedural updates. It fits best under Regulatory Filings (RNS) as it is a regulatory compliance communication without substantive financial or report content.
2025-09-12 English
Copy of Newspaper Publication
Regulatory Filings
2025-08-25 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement disclosure under Regulation 30 of SEBI Listing Regulations. It mentions the publication of an advertisement about the opening of a special window for re-lodgement of transfer requests of physical shares. The document is short (1417 characters) and serves as a regulatory announcement rather than a financial report or detailed filing. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures.
2025-08-25 English
Shareholders meeting
Regulatory Filings
2025-08-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.